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THE problem ofmalignancy as a complication ofradiation has become a subject
of major interest in recent years, primarily due to the increased use of radio-
elements in industry, the widespread application of radiation techniques in
medicine, and the concern with nuclear fall-out from weapons testing. Data oIn
experimental carcinogenesis have emphasised cause and effect relationships and
tumour incidence, but have provided little information on the antecedents of
tumour induction related to radiation dose and dose rate, tissue response, and
changes occurring between radiation exposure and the appearance of neoplasia.
Even less information is available from the relatively small amount ofhuman data
obtained from clinical studies of radiation-induced cancer.
Data gathered from clinical reports, however, particularly on localised radia-
tion, indicate that doses required for cancer induction may be of a magnitude to
produce some form of observable tissue damage (Cade, 1957 ; Cahan, Woodward,
Higginbotham, Stewart and Coley, 1948; Glucksmann, Lamerton and Mayneord,
1957). This may not necessarily be associated with the result of architectural or
cellular disorientation, since radiotherapeutic experience suggests radiation cancer
to be an unusual sequel. While certain malignancies appear to be causally related
to preceding irradiation, it is probable that the incidence of cancer following
irradiation may be higher than is apparent and that some tumours occur without
evidence of demonstrable radiation tissue damage.
Malignancy has been recognised as a late complication of radiation exposure
for over 50 years. A study ofradiation-induced cancer in man during this interval
reveals two periods ofincreased incidence. The first was due to occupational and
industrial exposure and affected those whose work brought them into contact with
radiation. The second period affected patients treated for benign or malignant
diseases and reports of these cases have appeared in the medical literature with
regularity during the past 25 years. It has become evident that both groups were
exposed to excessive external or internally administered radiation during an era
when the effects of ionizing radiations were poorly understood, dosimetry inac-
curate, and protection inadequate. This report deals with the second group, and
reviews the histories of six patients in whom cancer was induced as a consequence
ofradiation exposure made to treat a benign or malignant neoplasm or to establish
a radiological diagnosis following internal administration of a radioactive contrast
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material (thorotrast). These cases were studied and followed by the authors in the
Radiotherapy Department ofthe Johns Hopkins Hospital. In order to assess the
importance of the direct and indirect effects of radiation, relevant data on dose
and dose rates, latent periods, extent of tissue damage, and types of tumours
induced have been included whenever possible. These are discussed in terms of
possible mechanisms of radiation carcinogenesis at the clinical level to provide




A 49-year old male complained of intermittent hoarseness which had progres-
sively worsened during the previous 7 months. Examination revealed a squamous
cell carcinoma of the intrinsic larynx with involvement of the entire right vocal
cord, the anterior commissure, and the anterior one-third of the left vocal cord.
No lymph nodes were palpable. At total laryngectomy, it was found that tumour
invaded the thyroid cartilage and extended into the pre-epiglottic space. Post-
operatively, high voltage (250 kv., 1-8 mm. Cu HVL) radiotherapy was adminis-
tered through two 6 cm. x 10 cm. lateral opposing ports; however, the patient
elected to return to his home city for completion of radiotherapy after 300 r.
mid-line tissue dose had been delivered. The radiotherapist's report indicated
that the patient received an additional 4600 r. tumour dose in over 4 weeks
through similar lateral parallel opposing fields; the estimated daily midline tissue
dose was 162 r. The radiation quality is not known. On the completion of
therapy, the patient experienced a " brisk " skin reaction moderate dysphagia,
and soreness around the tracheostomy tube.
He did quite well following laryngectomy and radiation therapy until 8 years
later when he complained of progressive dysphagia and loss of weight (11 pounds)
for 3 months. He was unable to swallow food unless it was finely chewed or
chopped, but he did not experience any pain. On examination, he appeared
healthy and alert, breathed well through a healed tracheostomy, and spoke effec-
tively with the aid of an electronic larynx. The skin of his neck was firm and
inelastic with marked scarring and telangiectasia over the irradiated fields. A
barium swallow fluoroscopic examination (Fig. 1) demonstrated multiple, nodular,
polypoid irregularities involving the cervical oesophagus, extending up behind the
pharynx, and displacing the trachea anteriorly. The cervical oesophagus was
deviated to the right. The appearance was that of a retrotracheal and retro-
pharyngeal mass, and considered a probable recurrent carcinoma with secondary
invasion ofthe oesophagus. A hard, polypoid hypopharyngeal mass was observed
at endoscopy; however, a biopsy revealed no evidence oftumour and only chronic
inflammatory tissue with extensive fibrosis which was compatible with marked
radiation reaction.
The superior oesophagus was explored and when frozen section examination
revealed polypoid sarcoma suggestive of leiomyosarcoma, the cervical oesophagus
was resected and subsequent definitive procedures were to be based on the
pathological findings. The lesion was a large polypoid fibrosarcoma, well confined
to the oesophagus, with extensive dense fibrotic connective tissue and round cell
infiltration; the stigmata ofchronic radiation reaction and the classical appearance
of fusiform epithelioid sarcomatous cells suggested the tumour was radiation-
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induced. The lobulated mass arose diffusely from the mucosa over an area 5 cm.
in diameter to fill the lumen (Fig. 2) and replaced thesuperficial muscularis propria
and submucosa. The proximal oesophageal stump contained marked chronic
inflammatory changes with fibrosis and foreign body reaction, but no tumour was
present in the resected edge.
One week later an ileocolic transplant was performed; the terminal ileum and
ascending colon were brought up in a retrosternal position into the chest and neck
and anastomosed to the proximal stump ofthe cervical oesophagus. Ileotransverse
colostomy and gastrocolic anastomosis was done. His post-operative course
was complicated by abdominal distension and intermittent fever of unknown
origin which required exploratory laparotomy. Two days later, following a
cerebrovascular accident, he suddenly became comatose, developed left hemiplegia,
and died.
Comment (Case I)
This is the first patient with irradiation fibrosarcoma arising in the oesophagus
following radiotherapy known to the authors. In the Manchester Series reviewed
by Goolden (1957), one patient developed cancer in the oesophagus 35 years
following irradiation for thyrotoxicosis; the histological diagnosis was not
recorded, but the author definitely excluded sarcoma. Previously, Goolden (1951)
reported one patient with fibrosarcoma arising in the postcricoid region 30 years
following irradiation for hyperthyroidism, and Holinger and Rabbatt (1953)
described a fibrosarcoma arising from the aryepiglottic fold of the epipharynx
27 years after the patient had been irradiated for tuberculous lymphadenitis.
Som and Peimer (1955) reported two cases of postcricoid carcinoma following
irradiation for carcinoma of the larynx, but no cases are known where irradiation
sarcoma has arisen following high voltage deep radiotherapy for a previous
malignancy. Incomplete data make correlation between dose and type of cancer
induced difficult to assess, but it is generally recognised that the sarcomas arise
following higher tissue doses. The short interval period of 7 years in this patient
agrees more with the mean latency of irradiation bone sarcoma (8-6 years)
reported by Jones (1953) in a review series of 39 cases than with the interval of
25 to 30 years recorded by Goolden (1957) for 32' cases of irradiation carcinoma of
the pharynx and oesophagus, and with that of the industrial epithelial tumours
ofknown aetiology.
Case II
A 7-month-old baby girldeveloped unilateral exophthalmos squint, and a highly
vascularised sclera of the left eye; the right eye was normal. A large retino-
blastoma (endophytum type) was identified in the posterior chamber arising from
the infero-posterior portion of the retina. Roentgenograms revealed no involve-
ment of the osseous structures ofthe orbit, nor was there enlargement ofthe optic
foramen. The eye was enucleated, and a wide exenteration ofthe orbital contents
was performed. Pathological examination revealed the classical appearance of
true rosettes of carrot-shaped cells with scanty cytoplasm and hyperchromatic
nuclei; tumour extended through the outer coats of the eye, but there was no
invasion of the optic nerve or peri-orbital fat. Postoperative high voltage
radiotherapy (250 kv., 1 8 mm. Cu HVL) was administered; the radiation dose
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to the posterior wall of the orbit was estimated to be 2800 r. delivered through two
fields (antero-posterior and lateral) angled at 85 degrees to each other during a
period of 4 weeks. The child did well, and moderate skin reaction was noted in the
treated areas.
There was no evidence of recurrent tumour31 years later, but while the child
was being measured for aprosthesis, she complained of tenderness along the lateral
wall of the left orbit. Radiographs revealed early changes of radiation osteitis
but no overt bone destruction. Eighteen months later (5 years following surgery)
a large mass had become palpable and the child complained of continuous pain
and marked tenderness. X-ray examination demonstrated progression of the
osteitis previously noted, but now there were irregular osteolytic areas of destruc-
tion in the lateral orbital wall, most prominent in the left frontal bone (Fig. 3).
Biopsy of the mass was reported as fibrosarcoma. A wide excision was carried
out and revealed a dense spindle cell fibrosarcoma with occasional giant cells,
but no evidence of new bone formation. Chronic inflammatory changes of radia-
tion osteitis were identified in the adjacent bone. The child survived for 21 years
and died with generalised sarcomatous metastases. There was no recurrence of
the retinoblastoma.
Comment (Case11)
The induction of spindle cell fibrosarcoma following external irradiation has
been frequently described (Cahan, et al., 1948; Cruz, Coley and Stewart, 1957;
Jones, 1953); however, few reports are known to the authors of the development
of fibrosarcoma following radiation injury to bone in a young child and with a
brief latent interval of only 4 years. The criteria for post-irradiation sarcoma
established by Cahan et al. (1948) were fulfilled, namely (1) roentgenographic
evidence of normal bone before irradiation, (2) development of sarcoma in tissue
included in the radiotherapeutic beam, (3) a symptom-free latent interval and (4)
histological proof of sarcoma in previously normal bone and adjacent tissues. In
the cases of irradiation osteosarcoma reviewed by Jones (1953), the latent periods
varied from 3 to 22years with a mean interval of 8-6 years the age ofthe patients
ranged from 9 to 62 years. All occurred following external irradiation, but in
none could any phase during the latent period be recognised as osteoradionecrosis,
although in 13 patients the tumour arose in previously normal bone. An addi-
tional 14 cases of radiation sarcoma of the skull have been reported (Cruz et al.,
1957; Raventos, Gross and Pendergrass, 1960; Skolnik, Fornatto, and Heyde-
mann, 1956), and in none of these was radiation injury to bone observed to
precede malignant degeneration, although Cruz et al. (1957) referred to two
patients in whom radiographic evidence suggested radiation osteitis was ante-
cedent to the induction of sarcoma. Petit, Chamness and Ackerman (1954)
discussed fibrosarcoma in the deep connective tissues following external radiation
therapy in three patients, but none was related to radiation injury to bone.
Raventos et al. (1960) described the appearance of fibrosarcoma in the osseous
calvarium or in the overlying galea aponeurotica in a patient irradiated for a
pituitary tumour 17 years before, and in whom roentgenographic changes of
radiation osteitis had been present for 7 years. However, there was no histo-
logical evidence of radiation osteitis or radionecrosis in the tissue fragments
examined, and it was suggested that the osteolytic lesions observed roentgeno-
graphicallyrepresentedresorption, rather thannecrosis, following radiation injury
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to the calvarium. Since Case II had histological evidence of radiation osteitis,
the history of this child was similar to those patients of Aub, Evans, Hempel-
mann, and Martland (1952), Looney (1960) and others in whom sarcomas deve-
loped in regions ofradiation osteitis following the internaldeposition ofradioactive
nuclides (radium and/or mesothorium).
The clinical features of malignant change most frequently observed in the
patients of Cahan et al. (1948), namely, unremitting and progressively increasing
pain and swelling in an area which had been previously irradiated, were observed
in this patient. Although the clinical diagnosis of radiation osteitis was verified
it does not appear that the condition was followed radiographically to determine
interval improvement or deterioration. While sarcomatous degeneration could
not be confirmed without biopsy, malignancy could have been suspected from the
early osteolytic changes. Pathological experience indicates that a wide variety
of characteristic histological features of these sarcomas exist ; pleomorphic
spindle cell sarcomas may arise in intimate relation to osseous structures, but often
new bone is poorly formed or actually deficient. Thus, the roentgenographic and
microscopic features in Case II are somewhat similar to those described in the
patient of Raventos et al. (1960); the additional histological evidence of charac-
teristic radiation osteitis and necrosis preceding the development of fibrosarcoma
in this child was an important additional finding.
Case III
At 12 months of age, this boy received " X-ray treatments " to the tonsils for
tonsillitis and forhypertrophiedlymphoid tissue in the nasopharynx. The method
of application, radiation quality and dosage are not known, except that he was
given "three doses". At 14 years, he complained of spontaneous nose bleeds
and nasal obstruction on the left. Following mumps meningitis one year later,
leftexophthalmospersisted withoutdiplopia orheadache, but the child experienced
occasional bilateral tinnitus. Roentgenograms (Fig. 4) demonstrated complete
clouding of the left maxillary antrum with destruction of the left lateral sinus
wall and the lateral and inferior orbital walls by a malignant process. Destruction
and opacification extended into the ethmoid and sphenoid sinuses. He underwent
complete exenteration of the orbit and adjacent maxillary and ethmoid sinuses
to include the lateral wall of the sphenoid sinus. The tumour extended into the
nasopharynx and posteriorly into the retro-orbital fat, along the optic nerve and
into the foramen, into the surrounding bone, and involved the cribriform plate.
Histological examination revealed a highly anaplastic adenocarcinoma (adenoid
cystic type) of lacrimal duct origin with an extensive fibrovascular connective
tissue stroma, and chronic inflammatory changes with round cell infiltration and
foreign body reaction. Tumour was present in the posterior margin ofthe surgical
specimen. A mold containing two 25 mg. radium capsules in dental wax was
placed in the surgical defect ; this delivered 7000 r. at 0 5 cm. within the residual
tumour. External high voltage radiotherapy (250 kv., 1 8 mm. Cu HVL)
supplemented the radium therapy; 3000 r. tumour dose was administered in 6
weeks through two angled ports with shielding of the right eye.
Five months later he complained of unremitting pain in the left temporal and
occipital regions. He was unable to open his mouth due to ankylosis of the left
temporomandibular joint secondary to marked osteoradionecrosis and osteo-
myelitis of the ascending ramus of the left mandible. This required further
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extensive surgical care involving osteotomy with excision of the ascending ramus
and condyle of the left mandible and debridement of an orbital sequestrum
there was marked trismus of the left masseter and pterygoid muscles. The child
had a stormy postoperative period complicated by recalcitrant cellulitis and
abscess formation in the left cheek, and by a moderate depressive reaction. Three
years later. no recurrent neoplasm was observed.
(omiment (Case III)
Tumours of the lacrimal sac and duct are uncommon; only 124 cases have
been reported (reviewed by Ashton, 1958S). While these appear most frequently in
the fifth decade oflife, a case was recorded in a 13-year-old child. Ofthe malignant
tumours, epitheliomas are the most common. These are closely related histologi-
cally and developmentally to similar carcinomas arising in the nasal and paranasal
cavities since the lining epithelium of the sac and duct and the respiratory epithe-
lium develop along similar embryologic lines. The tumour usually follows
episodes of chronic inflammation, may undergo widespread proliferative changes
in the epithelium, and show invasive tendencies at an early stage. The more
malignant lesions are poorly differentiated and consist of irregular masses of
hyperchromatic, pleomorphic or cylindrical cells; cyst formation is common,
and proliferation ofmalignant cells may occur within the cysts in a manner similar
to intraductal carcinoma.
None of the cases reported suggest a previous history of radiation however,
since no indication that a specific inquiry about radiation was made, this informa-
tion may be frequently absent from chart histories taken before the relationship
between radiation and head and neck tumours was established. Goolden (1957)
described a number oftypes ofirradiation cancers arising in the upper air passages;
none of the 32 cases of pharyngeal cancer, however, arose in the nasopharynx,
paranasal sinuses, or lacrimal structures. A number of studies (Duffy and Fitz-
gerald, 1950 ; Simpson, Hempelmann and Fuller, 1955 ; Wilson and Asper, 1960)
report a high incidence of thyroid tumors in children and adolescents previously
irradiated in the neck and thoracic regions, most frequently for thymic or tonsillar
enlargement and hypertrophied lymphoid tissue in the nasopharynx; leukemias
and osteochondromas of the shoulder were the only other neoplasms observed in
the irradiated groups with significant frequency when compared with control
siblings. These findings raised the very important additional consideration
whether the infant or young child is more susceptible than the adult to radiation-
induced malignancy.
Case I V
In 1919, this 71-year-old female had irradiation to the left cervical lymph
nodes for tuberculous lymphadenitis. She subsequently developed marked
radiation scars in the overlying skin of her neck, but with only minimal subcu-
taneous induration. In 1953 she developed a large carcinoma in the left naso-
pharynx at the eustachian tube orifice which was treated as follows. A radium
mold placed in the nasopharynx and against the eustachian tube orifice delivered
5750 r. at 0 5 cm.; high voltage (200 kv.) external radiotherapy to the left maxil-
lary antrum delivered 4000 r. through 4 cm. x 4 cm. left lateral and right anterior
maxillary ports, and through an intra-oral cone 1400 r. air dose. The radiation
quality is not known.
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Four years later she presented with hoarseness and progressive dysphagia of
3 months' duration. There was no recurrence of her nasopharyngeal carcinoma
and her general physical examination was unremarkable except for a Grade II
apical systolic murmur with a history of rheumatic heart disease, mitral insuf-
ficiency and aortic stenosis. On fluoroscopic examination a barium meal demon-
strated her difficulty to initiate the swallowing mechanism and revealed the
extent to which an irregular tumour mass involved the hypopharynx and the
oesophageal lumen (Fig. 5). At laryngoscopy, an extensive carcinoma involving
both arytenoids, the epiglottis, cricopharyngeus, left pyriform sinus and the en-
trance to the oesophagus was observed; the true vocal cords moved slightly.
Biopsies, positive for squamous cell carcinoma, were obtained from the left
arytenoid. the left cricopharyngeus, and the left side ofthe petiole ofthe epiglottis.
Bronchoscopic examination revealed slight generalised irritation of the endobron-
chial tree, but no purulent material or other exudate.
Treatment consisted of rotational high voltage (250 kv. 1.8 mm. Cu HVL)
radiotherapy with shielding of the radiation scars on her neck. A total dose of
5000 r. in 17 treatments was delivered to the midline of the hypopharynx and
larynx. She developed a marked skin reaction with desquamation primarily on
the left side, while her right side showed only minimal skin changes. Because of
the soreness and mucositis in her mouth, radiotherapy was discontinued. At the
conclusion of treatment, she still experienced dysphagia but there was improve-
ment in her voice. Examination ofthe larynx at that time revealed some oedema
of the arytenoids, but no evidence of ulceration; the size of the mass had dimin-
ished considerably. Three months later her voice and ability to swallow were
much improved, although she had now developed a deep ulcer on the left arytenoid
which was considered as radiation necrosis. Six months following therapy, she
complained ofprogressive pain in her throat radiating to her left ear; the oedema
and ulceration of the treated structures had worsened and residual neoplasia
was observed. Her condition deteriorated and she died within one year with
extensive recurrence of her disease.
Comment (Case IV)
In the series reviewed by Goolden (1957) all of the 42 patients, in whom
radiation cancer developed in the deep tissues of the neck, had been treated pre-
viously with irradiation for a benign condition, primarily tuberculous lympha-
denitis and thyrotoxicosis. In none ofthe 32 patients in this group with radiation
cancer in the pharynx did carcinoma arise in the nasopharynx; in 31 it was
confined to the epipharynx, and in one to the oesophagus. In Case IV, the latent
interval of 34 years agrees well with the range of 10 to 35 years in that series, but
it is somewhat greater than the mean interval of 25-5 years. While the patient's
second carcinoma involving the extrinsic larynx and cervical oesophagus may have
been causally related to her irradiation 38 years before, it is probable that its
induction was accelerated by the second course of deep radiotherapy 4 years
previously. Clinical experience is lacking on the carcinogenic effects of chronic
or repeated doses of irradiation; however, experimental evidence has demon-
strated convincingly the enhanced carcinogenicity of chronic or repeated irradia-
tion, both from external X-ray and gamma radiation and from internally adminis-
tered radionuclides (Bensted, Blackett and Lamerton, 1961) which is manifested
by an increased percentage and earlier onset of tumours.
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There is an apparent increased frequency with which tumours of the pharynx,
induced following irradiation for tuberculous adenitis, have their primary site of
origin in the laryngopharynx; the majority ofthese are confined to the epiglottis,
aryepiglottic folds and lateral pharyngeal walls. These are relatively uncommon
sites for the distribution of cancer of the pharynx in woman where lesions arising
in the oropharynx and epipharynx are three to four times less frequent in females
than in males. Jones (1953), Goolden (1957), Cade (1957), and others stress the
clinical importance of overlying skin changes following heavy irradiation since
chronic radiodermatitis, fibrosis, telangiectasia, and subcutaneous induration are
often reliable indices of dosage in patients whose histories lack adequate physical
estimates of radiation dose. Repeated irradiation would accelerate the latent
period, and although frank neoplasia may not be present until the latent period
is completed, following this the development of a second malignancy may be
extremely rapid.
Case V
A 31-year-old female complained of chronic sinusitis and asthma since child-
hood. In 1950, a radiopaque liquid was instilled in the left maxillary antrum for
diagnostic examination; none of the fluid was removed. Eight years later she
presented with an acute exacerbation of her sinusitis; roentgenograms at that
time revealed residual contrast medium in the antrum. She was treated with
antibiotics and irrigations and drainage which removed most of the remaining
EXPLANATION OF PLATES
FIG. 1-.Case I. Barium swallow roentgenogram demonstrating a multinodular polypoid
tumour involving the cervical oesophagus 8 years following irradiation.
FIG. 2. Case I. Polypoid fibrosarcoma arising diffusely from the oesophageal mucosa.
FIG. 3. Case II. Reontgenographic evidence of irregular osteolytic destruction of the
lateral wall of the left orbit 5 years following irradiation.
FIG. 4. Case III. Clouding of the left maxillary antrum and the adjacent paranasal sinuses
and irregular destruction ofthe infero-medial wall ofthe orbit 13 years following irradiation.
FIG. 5. Case IV. Barium swallow roentgenograms demonstrating an irregular tumour mass
involving the hypopharynx and oesophageal lumen 38 years following the first, and 4 years
following the second course of irradiation. A. Anteroposterior, B. Lateral.
FIG. 6. Case V. Neoplasm involving the left maxillary sinus and adjacent structures 8 years
following antral instillation of thorotrast.
FIG. 8.-Case VI. Roentgenogram of the abdomen demonstrating hepatosplenomegaly with
aggregates of radiopaque deposits in the liver and spleen 19 years following thorotrast
hepatolienography.
FIG. 9. Case VI. Haemangio-endothelioma in the liver 19 years following thorotrast
hepatolienography.
FIG. 10. Case VI. Haemangio-endothelioma in the spleen 19 years following thorotrast
hepatolienography.
FIG. 11.-Case VI. Haemangio-endothelioma in the liver; thorotrast crystals are present
in the reticulo-endothelial cells. x 135.
FIG. 12. Case VI. Haemangio-endothelioma in the spleen; thorotrast crystals are present in
the reticulo-endothelial cells. x 135.
FIGe. 13.-Case VI. Autoradiography demonstrating alpha tracks from thorotrast crystals
in the liver. x 270 oil.
FIG. 14. Case VI. Autoradiography demonstrating alpha tracks from thorotrast crystals
in the spleen. x 270 oil.
466BRITISH JOURNAL OF CANCER.
.111 IIItrl 2f11111' T'M
3
4
Fabrikant, Dickson and Fetter.
VOl. XVIII, NO. 3.
IBRITISH JOURNAL OF CANCER.
5a
6
Fabrikant, Dickson and Fetter.




Fabrikant, Dickson and Fetter.
VOl. XVIII, NO. 3.I3RITISH JOURNAL OF CANCER.
.. ¶.. '...$; S',... '.




Vol. XVIII, No. 3.
12l:|s$.r':_,jL_-r!____
!_!!-2ii $D _|1
xtl$,> i -'i; l..+.,:w-'s$3g:,w,.''t*ttV<t$.......P8.i.Fi
Jrs QSE. *i f' > gj*XsF-
i$' . .. vb
4
Fabrikant. Dickson and Fetter.RADIATION CARCINOGENESIS
material. She subsequently underwent submucous resection for an intranasal
obstructive deformity and left ethmoidectomy; routine histological studies of
the resected material revealed anaplastic squamous carcinoma. One month later
she had a bulging, protruding mass in the left nasal cavity; sinus roentgenograms
(Fig. 6) demonstrated neoplastic involvement of the superior and lateral walls of
the maxillary antrum. A wide exenteration was performed, and consisted of
radical resection of the left antrum including the maxillary and ethmoid sinuses
the nasal septum, and portions of the sphenoid sinus and inferior orbital plate.
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FIG. 7. Case V. (A. C., Aug. 14, 1958.) Gamma spectrum of the radiopaque material
removed from the maxillary antrum compared with that of thorium-232. A Radiopaque
rriaterial. B Gamma spectruin 232Th in equilibrium (53 years).
and invading the surrounding bone. Frozen sections obtained from the periphery
of the surgical specimen were negative except for suspicious areas in the ethmoid
cells. A gamma spectrum was obtained on the remaining radiopaque material
(Fig. 7); comparison with the gamma spectrum ofthorium-232 in equilibrium for
52 years demonstrated an energy peak of 238 keV. in both spectra, thereby iden-
tifying the opaque material as thorotrast.
A 10 mg. radium tube in a nasopharyngeal lucite applicator was packed into the
surgical defect and a radiation dose of 6000 r. was delivered to the ethmoid region,
and 2000 r. at one cm. to the back of the eye. She was then treated with high
voltage (250 kv., 1-8 mm. Cu HVL) radiotherapy and a tumour dose of 6000 r.was
delivered through three ports. During the subsequent years she underwent
multistage surgical procedures including bone grafts and forehead and thigh
grafts for closure of the large surgical defect. Five years following surgery and
radiotherapy there was no evidence of recurrent disease, nor had a cataract
467J. I. FABRIKANT, R. J. DICKSON AND B. F. FETTER
developed in the left eye. She was well adjusted to her disability and led a
normal life which included driving a car.
Comment (Case V)
Because of its superior qualities as radiopaque colloidal suspension, thorotrast
has been used extensively during the past 30 years as a contrast medium for special
procedures in diagnostic radiology (Looney, 1960). It has been employed fre-
quently to examine the paranasal sinuses, and recently, attention has been drawn
to the carcinogenic hazards of residual thorotrast either permanently retained or
incompletely removed following intrasinusal instillation (Kligerman, Lattes and
Rankow, 1960; Feldman, Seaman and Wells, 1963). Case V represents the
tenth patient in whom neoplasia in the maxillary sinus developed following antral
injection of thorotrast for radiodiagnostic purposes. During the past decade,
Kligerman et al. (1960) reported four cases of carcinoma of the antrum, Feldman
et al. (1963) three cases, and Hofer (1952), Gros, Fruhling and Keiling (1955) and
Looney and Colodzin (1956) one case each. The mean patient age for the series
was 50 years (range 32 to 70) and the average latent interval between instillation
of thorotrast and malignant degeneration was 14-25 years (range 10 to 20). All
had histologically proven carcinoma with radioactivity detected in the tissue
specimen, antral washings or residual contrast material. Case V, therefore, was
the youngest patient and had the shortest latent interval ofany patients examined.
Since a history of sinusitis is invariably present, the concomitant chronic
inflammatory changes due to the retention of thorotrast may contribute to the
extent of mucosal thickening, polypoid formation, and clouding in the antrum
demonstrated on the roentgenograms. Not infrequently, migration of minimal
amounts of radiopaque medium into an adjacent paranasal sinus cavity has been
observed. When malignant degeneration has intervened, additional roentgeno-
graphic features often include destruction of bone, and in advanced lesions,
complete obliteration of the margins of the cavity. Feldman et al. (1963)
stressed the importance of recognition of retained thorotrast because of clinical
and experimental evidence concerning the frequency with which this diagnostic
radiopaque medium produced chronic inflammation and foreign body granulo-
matous reaction, and ultimately necrosis with malignant degeneration in tissue
in which it is retained (Guimaraes and Lamerton, 1956; Looney, 1960; Bensted
and Crookall, 1963).
Case VI
A 37-year-old male was admitted to the hospital complaining of fatigue of
4 months duration, and with anaemia, epigastric pain, and intermittent low-grade
fever for 4 weeks. Nineteen years previously he had had right-sided pleurisy with
associated right upper quadrant pain ; intravenous injection of 75 c.c. of thoro-
trast was used for roentgenographic evaluation to demonstrate, by means of
hepatolienography, a probable liver abscess. The study was inconclusive, and
under conservative management, the patient regained his health. He remained
well for 15 years when he began to notice extreme fatigue and cervical lymph-
adenopathy. Biopsy at that time revealed hyperplastic adenopathy; he was
treated with local irradiation without recurrence. On the present admission,
physical examination revealed cervical lymphadenopathy and a palpable liver;
he had a diurnal fever which never rose above 1010 F. Gastro-intestinal and
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barium enema fluoroscopic examinations done at another hospital were reported
as negative. The haematological studies were:
Haemoglobin . . . . 9 g. per cent
White blood cell count . . 11,000 per mm3
Differential
Neutrophiles . . . 53 per cent
Stabs . . . . . 13 per cent
Eosinophiles . . . 5 per cent
Monocytes . . . 9 per cent
Lymphocytes . . . 5 per cent
Occasional metamyelocytes
Roentgenograms of the chest revealed patchy bronchopneumonia. A flat
film of the abdomen demonstrated hepatosplenomegaly with aggregates of
radiopaque deposits in the liver and spleen (Fig. 8). A sternal bone marrow
aspiration revealed " many pleomorphic tumour cells ", and the diagnosis of
metastatic neoplasm ofunknown origin was made. The patient was treated with
triethylene melamine (11.5 mg. intravenously, total administered dose for a period
of 17 days). One month later he developed jaundice and generalised oedema,
and was treated with urethane. He failed to respond, deteriorated rapidly, and
died after 4 weeks.
At autopsy, neoplastic foci were found in the liver (Fig. 9), spleen (Fig. 10),
bone marrow, lymph nodes, adrenals, kidneys, and implanted in the dura. The
cut surfaces of the liver and spleen contained numerous small tumours which, on
microscopic examination, were composed of large and irregularly shaped spaces
filled with blood and lined with proliferating, spindle-shaped epithelioid cells and
reticular cells with hyperchromatic nuclei (Fig. 11 and 12). Large numbers of
reticulo-endothelial cells contained thorium crystal aggregates; larger aggregates
were present in the supporting stroma, primarily in dense bands offibrous connec-
tive tissue. The neoplasm was classified as an haemangio-endothelioma.
Scintillation analyses of thorium deposits in representative samples of fixed
liver tissue yielded gamma activities of 266 ,u,c and 189 I,tc thorium-232 per g.
andalphaemission activities (zinc sulfide crystal emanations) of 100 a and 40 c per
cm2 per hour. Alpha tracts were readily demonstrated in emulsion-dipped
autoradiographs of liver (Fig. 13) and spleen (Fig. 14) exposed for 4 weeks.
Comment (Case VI)
When thorotrast is injected intravenously, the particles are taken up by the
reticulo-endothelial system, and the organs which show the greatest concentrations
ofaggregates ofcrystal are the liver, spleen, bone marrow and lymph nodes. The
use of thorotrast clinically for hepatolienography to visualise the reticulo-endo-
thelial system has resulted in the infrequent induction of primary sarcomas,
carcinomas, and mixed neoplasms in the liver. Looney (1960) cited ten cases in
the literature of hepatocellular and cholangiocellular carcinoma in patients pre-
viously given thorotrast for such radiodiagnostic procedures. Since hepatic
carcinomas are associated with other pathological conditions of the liver (e.g.
cirrhosis), and since in most of these patients thorotrast was administered to
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diagnose and evaluate hepatic disease, it is difficult to assess the role of pre-can-
cerous conditions which may have existed at the time of the administration of
thorotrast and the extent to which the material may have accelerated the
induction of malignancy.
Experimental evidence available to establish a relationship between the induc-
tion of primary hepatic neoplasms and thorotrast is concerned with cancers of
mesodermal origin. Johansen (1954) produced hepatic reticulo-endotheliomal
sarcomas in rabbits; Selbie (1936) and Guimaraes and Lamerton (1956) have
reported similar reticulo-endotheliomas and haemangio-endotheliomas in the
liver and spleen of rats and mice. Looney, Hursh, Colodzin and Steadman (1960)
described two cases of hepatic sarcomas arising in patients 23 years and 17 years
following the intravenous administration ofthorotrast. The first was a haemangio-
endothelioma, histologically similar to the rare spontaneous Kupffer cell sarcomas
(or haemangio-endotheliomas) described by Baker, Paget and Davson (1956) in a
series of 28 cases of tumours arising from the sinusoidal endothelium of the liver.
The second patient had a multinodular primary hepatic neoplasm, the microscopic
description of which was unavailable. Nine other patients with primary hepatic
sarcomas developing following thorotrast hepatosplenography have been reported
(Looney, 1960); the earliest of these malignancies appeared within 38 months of
the time ofinjection. While histologically similar, four were classified as hepato-
sarcomas, three as haemangio-epitheliomas, and two as endothelial cell sarcomas.
On the basis of clinical and experimental material available, Looney (1960)
suggested that the haemangio-endothelioma was almost a thorotrast-specific
tumour. He referred, however, to the occurrence ofthree similar hepatic tumours
in a group of 25 vineyard wvorkers with chronic arsenic poisoning described by
Roth (1957) and discussed the controversy whether thorotrast tumours arose
from the effects ofradiation only, or whether the carcinogenic effect may be related
to some extent to the physical presence of the particulate material in the tissue or
even to chemical properties of thorium. If these effects are related to tissue
damage and repair resulting from radiation from thorium and its daughters, there
was no evidence in the studies of Guimaraes and Lamerton (1956) or Bensted and
Crookall (1963), who found no indication that tissue destruction ofany significance
preceded the development ofliver neoplasia in rats and mice although the radiation
dosage was very large. Selbie (1936) observed fibroblast proliferation at injection
sites in the subcutaneous tissues of many of his thorotrast-tumour rats and sug-
gested that neoplasia developed in those animals which gave a vigorous inflamma-
tory reaction to the presence of thorotrast. Clinical reports on the late sequelae
of extravasation of thorotrast following intravenous or intra-arterial injection have
supported these experimental observations of extensive inflammatory response
with the development of marked fibrosis and foreign body granulomas. Bensted
and Crookall (1963) found no difference in the incidence of hepatic tumours in a
comparison in mice of the late effects of thorotrast and zirconotrast, a non-
radioactive colloidal contrast medium. Upton, Furth and Burnett (1956) have
studied the effects of radioactive colloidal gold and concluded it was not neces-
sarily the colloidal state ofthe material which rendered it carcinogenic for the liver.
While a number ofstudies have emphasized the possible role ofcirrhosis and related
biochemical factors in the livers of thorotrast patients, no recent experimental
evidence is available to indicate induction ofliver damage and cirrhosis in rats and
mice following administration of thorotrast. The picture is further complicated
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by the report of Ross (1932) of a patient in whom a haemangio-endothelioma in
the liver was observed 3 years after a radium needle inadvertently lodged in the
septum of the heart. If this rare neoplasm was caused by radiation at a distance
from the liver, this would suggest that thorotrast tumours may arise from radiation
damage rather than from direct physical or chemical factors.
The haematological studies in Case VI were similar to those of patients in the
large series of Looney (1960), and while no predominant picture prevailed in these
patients, it was not unusual to find anaemia and an increase in the early forms of
the myeloid series. Since bone marrow is a favoured site for thorotrast deposition.
destruction of erythropoietic and myelopoietic tissues and the subsequent appear-
ance of circulating immature blood cells could be expected.
DISCUSSION
Radiation dosage in radiotherapy
The least well documented data on the carcinogenic effects of radiation are
those concerned with radiation cancer in man. Relatively few cases of neoplasia
which can be directly related to the previous therapeutic irradiation have been
described, and these provide only minimum information concerning radiation dose
and dose rate, volume oftissue irradiated, andpredisposing factors which may have
existed at the time of irradiation. Since it is not possible to estimate the total
population at risk following radiotherapy, it becomes extremely difficult to relate
the small number of cases to frequencies of tumour incidence and radiation
exposure.
Inadequate historical data in Cases I to IV prevent precise correlation of sites
and incidence of tumours with tissue dose, but these cases support observations
that the risk of radiation malignancy is present with doses in the accepted radio-
therapeutic range (Table I). The fibrosarcoma of the oesophagus (Case I)
TABLE I.-Summary of Case Studies of Radiation Induced Cancer
Original lesion Radiation lesion Age at time Latent Estimated
of period Dose
irradiation
I. Carcinoma larynx Fibrosarcoma, . 49 years . 8 years . 4600 r.
cervical
oesophagus
II. Retinoblastoma Fibrosarcoma, orbit 7 months 4-5 years 3800 r.
III. Hypertrophied Anaplastic . 12 months 13 years see text
lymphoid tissue carcinoma, lacrimal,
nasopharynx maxillary sinus
IV. Tuberculous Carcinoma, 33 years . 31 years
adenitis nasopharynx
Carcinoma, larynx 65 years 35 years see text
VT. Chronic sinusitis Anaplastic 23 years 8 years . see text
carcinoma,
ethmoid sinus
VI. Abdominal pain Haemangio- 19 years 19 years see text
?Liver abscess endothelioma
developed in soft tissue after 4900 r., which is within the range of 3000 r.-5000 r
reported in a number ofclinical studies ofosteosarcomas, fibrosarcomas, and chon-
drosarcomas appearing following radiation therapy for benign or malignant
conditions (Cahan et al., 1948; Jones, 1953; Sabanas, Dahlin, Childs and Ivins,
20
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1956). In the young child with fibrosarcoma in the osseous structures ofthe orbit
(Case II), the determination ofradiation dose absorbed in bone is concerned with a
number of additional factors. Spiers (1951) has shown that depending upon the
radiation quality and the region ofabsorption within the bone, the radiation dose
may be considerably greater than in the soft tissue for the same dose in roentgens.
Thus, in the orthovoltage range, for a dose of 2800 r. estimated in the centre of
the orbit, the radiation dose absorbed on the surface ofthe adjacent bone may be of
the order of 8500 r. This does appear to represent an excessive dose which could
induce radiation malignancy, and raises the important consideration as to whether
the tissues of the young child are more susceptible than those of the adult.
Simpson andHempelmann (1957) havereportedfive casesofosteochondromainthe
shoulder in children irradiated in the neck region in infancy; the minimum skin
dose recorded was 125 r.
From radiotherapeutic experience, good clinical response was claimed from
irradiation of enlarged tonsils and adenoids, either by X-rays applied externally
in small dosage, or by radium applicators introduced into the oral cavity or the
nasopharyngeal space. The details ofradiation dosage in Case III remain obscure,
but since the dosage scheme for external radiotherapy ofthe order of50 r. to 100 r.
air dose for each exposure was an accepted method, it may be assumed that the
tissue dose absorbed would be in the range of 165 r. to 330 r. for " three doses ".
While this represents a small radiation dose the data of Simpson et al. (1955) and
Clark (1955) on children who developed cancer of the thyroid, leukaemia and
osteochondromas following previous irradiation to the thymus and neck region
with skin doses as low as 125 r. may suggest a greater radiation susceptibility
to malignant induction in tissues of infants and young children than in adults.
In the past, tuberculous cervical adenitis frequently responded to treatment with
small doses of X-rays applied at weekly intervals for some 6 to 8 weeks; the
radiation dosage was ofthe order of50 r. to 100 r. in air for each exposure. While
no data is available for Case IV, it is probable that she received a tissue dose of at
least 400 r. to 750 r. ; radiation scars were observed on her neck from previous
therapy. Goolden (1957) and Cade (1957) do not present sufficient data on radia-
tion dose absorbed in those patients who subsequently developed carcinoma of
the pharynx and larynx, but draw attention to the frequency ofdamage to the skin
and subcutaneous tissues as an index of radiation dose. While extensive tissue
damage has been considered important for the induction of radiation cancer, the
range of low doses delivered for benign conditions suggests that no evidence
exists for a threshold dose below which radiation carcinogenesis does not occur.
The second course of irradiation, however, may have contributed an additional
2000 r. to 4000 r. to the deep structures of the neck, thereby bringing the total
radiation dose into the range of cases reviewed by Jones (1953). The evidence
suggests that the latent period for the second radiation cancer may be shortened
by the additional therapy due to acceleration ofexisting pre-malignant changes in
progress, particularly in view of a history of predisposing conditions of infection
and irradiation.
Radiation dosefrom thorotrast
Thorotrast (thorium dioxide sol) is a stable, highly dispersed sol which consists
of 24-26 per cent thorium dioxide by volume, 20 per cent dextran, and 0415 per
cent methyl-p-hydroxybenzoate as a preservative. The size of the thorium
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particles range from 3 to 10,t. The decay series of thorium-232 contains eleven
radioactive daughter products (with branching at polonium-216 and bismuth-212):
the series ends in stable lead-298. The radionuclides of the series emit alpha,
beta or gamma radiations of varying energies; the longest half-life of these is the
alpha emission of thorium-232 with 1P39 x 1010 years.
The inhomogenous radiation produced by alpha emitters, and the non-uniform
and patchy anatomical distribution of thorotrast, complicate any attempt at
calculation of radiation dosage to the tissue. Correlation with histopathological
findings based on terminal burdens is suspect since the uneven and irregular
distribution with increasing aggregation and flocculation of thorotrast granules,
and migration and redistribution of thorium are constantly changing levels of
radiation dose. Furthermore, some of the decay products of the complicated
thorium series are soluble and bone-seekers. Thus, average dose to tissue is a
meaningless concept, and calculations based on terminal burdens do not neces-
sarily represent the radiation doses which may be responsible for initiating malig-
nant processes.
For hepatosplenography, 75 c.c. of thorotrast injected intravenously was
usually given in 25 c.c. amounts daily or every other day. This amount would
be the equivalent of 15 g. of thorium dioxide and would represent 2 1 ,ug. radium
equivalent alpha emission. The energy ofemission would be 2-5 x 105 MeV./sec.;
radiothorium and other daughter products would eventually build up in a compli-
cated manner into equilibrium at which time the energy emission would be
2-2 x 106 MeV./sec. (Rundo, 1956). The parent thorium-232 is retained almost
indefinitely in the reticulo-endothelial system of the liver and spleen; the biologi-
cal half-time for thorium is of the order of 400 years. Assuming indefinite
retention following intravenous administration, some 70-75 per cent would be
deposited in the liver, 10-15 per cent in the spleen, and 5-10 per cent in the bone
marrow; the estimated average radiation doses would be 1-5, 2-5, and 0-3 rads
per week in these organs respectively (Looney, 1960).
Thus, determination of radiation dose rate associated with the development of
haemangio-endothelioma is complicated by (1) the non-uniformity of distribution
of the radionuclides in the tissue, (2) the intricate decay scheme of thorium-232
and the activities of its daughter products over an extended period, and (3) the
effects of geometrical size and shape of the thorium aggregates in the tissue on
energy emission and absorption. Following injection, thorotrast flocculates
and is deposited in aggregates or granules up to 100 1t in diameter; this is greater
than the ranges in tissue of the alpha particles (the most energetic, polonium-212,
has a range of 85 Iu) and results in substantial self-absorption. In Case VI,
representative samples of liver examined by alpha scintillation counting revealed
an emission of 100lx percm.2 per hour and 40 a percm.2 per hour. Determination
of thorium-232 activity in these specimens by gamma spectrometry indicated
approximately 270 ,C 232Th per g. and190,uc 232Th per g. Based on data of
Marinelli (1958), and estimates of Rundo (1961), Hursh, Steadman, Looney and
Colodzin (1957) and Rotblat and Ward (1956), an approximation of mean radiation
dose to the liver following intravenous injection of 75 c.c. of thorotrast (232Th and
daughters; RBE 4-10) would be100 rads per year and an estimated mean
accumulated dose in the order of 8000 to 10,000 rads after 19 years. Rundo (1961)
suggested an extra 5 to 10 per cent contribution from beta particles and 2 to 5 per
cent from gamma rays. This agrees with average estimated radiation dosages to
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the liver ofthe order of 700 to 15,000 rads in patients with terminalbody burdens of
thorium-232 studied by these authors.
Predisposing Factors
The data available from clinical experience provide little material to under-
stand the role of predisposing factors in the mechanisms of radiation carcino-
genesis. A pattern emerges, however, which suggests that (1) the doses of radia-
tion required to induce certain tumours were ofthe order ofthousands ofroentgens
and (2) the doses were of a magnitude that produced severe tissue damage since,
in almost all cases studied, it appeared that extensive tissue damage preceded the
appearance of cancer. Certain inflammatory processes, e.g., tuberculosis, osteitis,
etc., appear to enhance the carcinogenic effect of irradiation. Since frequently
protracted periods of treatment to relatively high doses are necessary in radio-
therapy of malignant disease, it may be the radiation itself which supplies the
inflammatory factor by the stromal response in those instances where evidence of
previous inflammation is lacking. These observations suggest that the type and
degree of tissue damage induced may be more important than the radiation dose,
and that neoplasia may develop in regenerating tissue during processes of repair.
Latent periods
The controversial concept oflatent interval applied to experimental studies has
been criticised for lack of precise definition of mechanisms which are operating
between the time of administration of radiation and the earliest identification of
induced neoplasia. Clinically, however, a latent interval may be defined as the
period of time between exposure to radiation (or the last treatment cycle in radio-
therapy) and the development of clinical cancer. For Cases I to VI, the latent
intervals varied between 4 and 34 years. This period has little meaning, however,
in the thorotrast patients, where in the course ofthe disintegration ofthorium and
its daughter elements, alpha, beta, and gamma radiations are continuously emitted
from the thorium deposits in the reticulo-endothelial tissues. In addition, diffi-
culty arises to determine suitable latent intervals in those patients whose treat-
ment extended over several months or years, and in those instances where two
or more courses of therapeutic radiation were separated by many years. While
clinical latent periods are difficult to ascertain, they definitely appear to be
reduced with higher doses of radiation and where tissues have been irradiated in
the presence of inflammatory disease.
Insufficient human data are available to correlate latent intervals with age at
the time of irradiation, and sites and types of tumour induction. Jones (1953
estimated a mean latent interval of about 9 years for irradiation sarcomas in bone
where the doses reported were some 3000 r. to 5000 r. or more. Cases I and II,
both irradiation sarcomas, fit into this group with relatively short latent intervals.
In the series of Goolden (1957), the latent interval range of 10 to 35 years (mean
25-5 years) for radiation carcinomas in the pharynx may suggest that the interval
for the development of carcinoma could be greater where small radiation doses
are involved. Cases III and IV would support these findings. The clinical
intervals for the thorotrast patients fall between these two extremes, and while
sarcomas and carcinomas result from the internal fixation of this radionuclide, it
is interesting that the interval range and mean period for induction of both types
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of neoplasia in the two distinct clinical groups of patients are almost identical
(Table II).
TABLE II.-Latent Intervalfor Thorotrast Patients
Range INMean
Number of '-
Neoplasm Patients Reference (years)
Carcinoma of 10 Feldman et al. (1963) 10-20 13- 6
maxillary sinus Case V
Haemangio- 9 Looney (1960) 8-22 15-4
endothelioma Case VI
CONCLUSIONS
The problem of the incidence of cancer following the medical use ofradioactive
materials is receiving considerable attention. Bone-seeking radionuclides,
particularly alpha-emitters, formed in nuclear energy processes are being studied
to determine possible carcinogenic properties and to learn about the processes of
tumour induction with these materials. Thorotrast tumour patients represent
important clinical material to evaluate and compare the late effects of continuous
low level irradiation and to provide information on the biological mechanisms of
radiation carcinogenesis in man. Although 62 cases ofthorotrast cancer have been
reported, there are, as yet, no comprehensive statistics on incidence, dosage, or
usage. Thus, any additional data on previous material or on new cases represent
important and substantial contributions to our scanty knowledge of the biological
actions of internally deposited radionuclides, and particularly for the study of the
effects of chronic irradiation by alpha particles in man. Thorotrast has been used
extensively in diagnostic radiology, and it is expected that an increase in clinical
material will become available which may be studied by epidemiological methods
as advocated by Marinelli (1961). In addition, while these patients do not contri-
bute significantly to information on genetic dose in the population, they do
represent available cases for clinical studies to further our understanding of
maximum permissible levels of body burden for radionuclides.
The hazards to patients from diagnostic procedures in radiology are extremely
small. Stewart, Webb, and Hewitt (1958) claim that prenatal obstetrical radio-
diagnostic examination may be related to the subsequent development ofleukaemia
or other cancers in the child. Further extensive studies to establish relationships
between such diagnostic exposures and childhood malignancies are required.
Although human data from radiotherapy, radium ingestion and thorotrast
administration suggest that tumour production is a rare sequel of radiation
exposure, particularly for dose ranges such as those used in radiotherapy, it is
possible that therapeutic radiation by megavoltage apparatus and artificial
radioisotopes may result in a further increase of radiation cancer incidence in the
future. A certain morbidity must be accepted if we are to derive the benefits of
accurate radiological diagnosis and effective treatment of malignant disease with
radiation. The very small risk ofradiation cancer should never become a deterrent
to the medical uses of radiation, since the elimination of all risk would apply
equally to all therapeutic measures, radiation or otherwise. The remote danger
of producing a new tumour by radiation has to be accepted where this form of
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treatment constitutes the only hope and practical and reliable means ofeliminating
an existing malignancy and thus preserving or prolonging the life of the patient.
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